Mariner
HAE icon

Mariner’s Haemonetics HAE Stock Holding History

Mariner’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$836K Buy
14,851
+3,760
+34% +$245K ﹤0.01% 2099
2025
Q4 		$890K Buy
+11,091
New +$745K ﹤0.01% 2026
2024
Q3 		– Sell
-2,727
Closed -$226K – 3334
2024
Q2 		$226K Buy
2,727
+315
+13% +$27.7K ﹤0.01% 2679
2024
Q1 		$206K Buy
+2,412
New +$189K ﹤0.01% 2748
2023
Q4 		– Sell
-2,357
Closed -$211K – 3107
2023
Q3 		$211K Buy
+2,357
New +$210K ﹤0.01% 2459

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mariner's HAE Position: Q1 2026 in Review

Mariner increased its Haemonetics (HAE) stake by 34% in Q1 2026, buying an estimated $245K and bringing the position to 14,851 shares worth $836K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Mariner first reported a position in HAE in Q3 2023 and has held it in 5 quarters since. The position peaked at $890K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Mariner held 14,851 shares of Haemonetics worth $836K as of Q1 2026.
  • Mariner bought 3,760 Haemonetics shares in Q1 2026, an estimated $245K.
  • Haemonetics made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2099 holding.
  • Mariner first reported a position in Haemonetics in Q3 2023 and has held it in 5 quarters since.
  • Mariner's Haemonetics position peaked at $890K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.